Role of Kushmand Paak in treating Male Infertility
DOI:
https://doi.org/10.47552/ijam.v13i3.2903Keywords:
Male infertility, Vajikaran chikitsa, Kushmand paak, Benincasa hispidaAbstract
ABSTRACT:
Objectives: To evaluate the efficacy of Ayurvedic herbal drug combination as a good and effective ability treatment on sperm production without any side effects on prolonged use.
Materials & methods: It was a self-control clinical trial study. In this study, we enrolled 40 patients having complaints of infertility. of age 25-40 years married for not less than 3 years. All these participants were advised to take 30 g of Kushmand Pak after mid meals with a cup of warm milk for 3 months. Sperm count, semen color, viscosity, and state were recorded before starting the treatment and after 3 months of completion of treatment.
Results: It was observed that ‘Kushmand Pak’ was accepted by all with no complaints about any side effects. Viable, active, and morphologically perfect sperm count was also increased to a significant level.
Conclusion: Kushmand Pak can be used to improve sperm count without any side effects on prolonged use.
Keywords: Male infertility, herbal drugs, Kushmand Pak
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.